{
    "clinical_study": {
        "@rank": "107634", 
        "arm_group": [
            {
                "arm_group_label": "Group A - Nonsmokers", 
                "description": "Nonsmoker is defined as someone who has smoked <100 cigarettes or <10 shisha pipes per lifetime and whose urine nicotine <2 ng/mL and/or urine cotinine <5 ng/mL, at entry into the study."
            }, 
            {
                "arm_group_label": "Group B - Current cigarette smokers", 
                "description": "Active smoker is defined by self-report and urine nicotine >30 ng/mL and/or urine cotinine >50 ng/ml."
            }, 
            {
                "arm_group_label": "Group C - Current shisha smokers", 
                "description": "Shisha smoker is defined by self-report of smoking >4 pipes/wk and carboxyhemoglobin >2.5."
            }, 
            {
                "arm_group_label": "Group D - Current smokers who stop smoking", 
                "description": "Current smoker is defined by self-report and urine nicotine >30 ng/ml and/or urine cotinine >50 ng/ml. Subjects must be a current smoker willing to stop smoking. Subjects in Group D will stop smoking after the baseline bronchoscopy, and switch to taking a smoking cessation medication called varenicline. We will provide subjects with the smoking cessation medication as part of this study. They will also receive phone calls to help with smoking cessation counseling."
            }, 
            {
                "arm_group_label": "Group E - Current smokers who switch to electronic cigarettes", 
                "description": "Current smoker is defined by self-report and urine nicotine >30 ng/ml and/or urine cotinine >50 ng/ml. Subjects must be willing to switch from tobacco cigarettes to electronic cigarettes. Subjects in Group E will switch to using electronic cigarettes after the baseline bronchoscopy. The nicotine dose that will be given to each subject will be determined by the study physician based on the urine smoking metabolite test. It will be adjusted depending on whether the subject is a light smoker or heavy smoker. Light smoker is defined as having either a urine nicotine value from 2ng/ml-1000ng/ml or a urine cotinine value from 5ng/ml-1000ng/ml. Heavy smoker is defined as having either a urine nicotine or cotinine value of over 1000ng/ml. We will provide the subjects with the electronic cigarettes to use as part of this study."
            }
        ], 
        "biospec_descr": {
            "textblock": "Analysis performed will be completed per the \"Airway\" (IRB#1204012331) protocol."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Cigarette smoking evokes major changes in the biology of the airway epithelium, the cell\n      population that takes the brunt of the stress of cigarette smoke and the cell population\n      central to the pathogenesis of chronic obstructive pulmonary disease (COPD) and lung cancer.\n      The focus of this study is to identify the differences that two popular alternative nicotine\n      delivery strategies, shisha and electronic cigarettes, have on the airway epithelium\n      compared to cigarette smoking. We hypothesize that both alternative nicotine delivery\n      strategies disorder airway epithelial biology, but in different ways than does cigarette\n      smoking."
        }, 
        "brief_title": "Alternate Nicotine Delivery Systems and Airway Epithelial Biology", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Smoking", 
            "Smoking Cessation"
        ], 
        "condition_browse": {
            "mesh_term": "Smoking"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Group A - Nonsmokers\n\n          -  All study subjects should be healthy according to the Weill Cornell IRB protocol\n             #1204012331 and be willing and able to provide informed consent for the follow up\n             study with repeated bronchoscopies.\n\n          -  Subjects will be male and female \u226518 yr of age.\n\n          -  Nonsmoker is defined as someone who has smoked <100 cigarettes or <10 shisha pipes\n             per lifetime and whose urine nicotine <2 ng/ml and/or urine cotinine <5 ng/ml, at\n             entry into the study.\n\n        Group B - Current cigarette smokers\n\n          -  All study subjects should be healthy according to the Weill Cornell IRB protocol\n             #1204012331 and willing and able to provide informed consent for the follow up study\n             with repeated bronchoscopies.\n\n          -  Subjects will be male and female \u226518 years of age.\n\n          -  Active smoker is defined by self-report and urine nicotine >30 ng/ml and/or urine\n             cotinine >50 ng/ml.\n\n        Group C - Current shisha smokers\n\n          -  All study subjects should be healthy according to the Weill Cornell IRB protocol\n             #1204012331 and willing and able to provide informed consent for the follow up study\n             with repeated bronchoscopies.\n\n          -  Subjects will be male and female \u226518 yr of age.\n\n          -  Shisha smoker is defined by self-report of smoking >4 pipes/wk and carboxyhemoglobin\n             >2.5.\n\n        Group D - Current smokers who stop smoking\n\n          -  All study subjects should be healthy according to the Weill Cornell IRB protocol\n             #1204012331 and willing and able to provide informed consent for the follow up study\n             with repeated bronchoscopies.\n\n          -  Subjects will be male and female \u226518 years of age.\n\n          -  Current smoker is defined by self-report and urine nicotine >30 ng/ml and/or urine\n             cotinine >50 ng/ml.\n\n          -  Subjects must be a current smoker willing to stop smoking with no contra indications\n             to taking varenicline.\n\n        Group E - Current smokers who switch to electronic cigarettes\n\n          -  All study subjects should be healthy according to the Weill Cornell IRB protocol\n             #1204012331 and willing and able to provide informed consent for the follow up study\n             with repeated bronchoscopies.\n\n          -  Subjects will be male and female \u226518 years of age. Current smoker is defined by\n             self-report and urine nicotine >30 ng/mL and/or urine cotinine >50 ng/ml.\n\n          -  Subjects must be willing to switch from tobacco cigarettes to electronic cigarettes.\n\n        Exclusion Criteria:\n\n        All exclusion criteria apply from the \"Airway\" (IRB#1204012331) protocol. Additional\n        exclusion criteria specific to this protocol are as follows:\n\n        Groups A-E\n\n        -  No Weill Cornell (including GMS) students will be included, but students from other\n        institutions may be included. A potential pool of Weill Cornell employees may enter this\n        study provided that they are not under the oversight of the study PI or co-investigators.\n\n        Groups D and E - Current smokers who stop smoking\n\n        - Subjects who are not, in the opinion of the responsible investigator, eligible to take\n        smoking cessation medication due to major depressive and/or other significant psychiatric\n        disorder."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "New York Metropolitan area residents"
            }
        }, 
        "enrollment": {
            "#text": "125", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974063", 
            "org_study_id": "1208012965", 
            "secondary_id": "1R01HL107882-01"
        }, 
        "intervention_browse": {
            "mesh_term": "Nicotine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Smoking", 
            "Smoking Cessation", 
            "Healthy Smoker", 
            "Shisha Smoker", 
            "Non-smoker"
        ], 
        "lastchanged_date": "October 25, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine"
                }, 
                "investigator": [
                    {
                        "last_name": "Robert Kaner, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ben-Gary Harvey, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ann Tilley, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dorothy Ryan, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jenny Yee-Levin, PA", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Rockefeller University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Robert Kaner, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ben-Gary Harvey, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ann Tilley, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dorothy Ryan, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "5", 
        "official_title": "Alternate Nicotine Delivery Systems and Airway Epithelial Biology", 
        "overall_contact": {
            "email": "chollman@med.cornell.edu", 
            "last_name": "Charleen Hollman, PhD, MPA, RN", 
            "phone": "646-962-2672"
        }, 
        "overall_contact_backup": {
            "email": "mig2037@med.cornell.edu", 
            "last_name": "Mitch Greene, MA", 
            "phone": "646-962-2672"
        }, 
        "overall_official": {
            "affiliation": "Weill Medical College of Cornell University", 
            "last_name": "Ronald G Crystal, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will measure the effect that shisha smoking has on the small airway epithelium (SAE) by measuring parameters such as the SAE gene expression, DNA methylation, telomere length and cilia length in \"pure shisha smokers\" (i.e., non-cigarette smokers.) We will compare these parameters to the same parameters  measured in non-smokers and cigarette smokers.", 
            "measure": "Number of participants with gene expression changes in the small airway epithelium (SAE)", 
            "safety_issue": "No", 
            "time_frame": "Study individuals will be enrolled in the study for three months."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974063"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "We will measure the small airway epithelium (SAE) of cigarette smokers who switch to smoking electronic cigarettes by measuring parameters such as the SAE gene expression, DNA methylation, telomere length and cilia length. We will compare these parameters to the same parameters measured in cigarette smokers who stop smoking completely.", 
            "measure": "Number of participants with gene expression changes in the airway epithelium", 
            "safety_issue": "No", 
            "time_frame": "Study individuals will be enrolled in the study for three months."
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}